|
Cardiac Resynchronization Therapy Devices
|
D058409 |
[Artificial pacemakers with implantable leads to be placed in the RIGHT ATRIUM and both HEART VENTRICLES. They are used to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles.
, Types of artificial pacemakers with implantable leads to be placed at multiple intracardial sites. They are used to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles. They may or may not include defibrillating electrodes (IMPLANTABLE DEFIBRILLATORS) as well.
] |
|
NK Cell Lectin-Like Receptor Subfamily A
|
D23.101.100.920.500 |
|
|
Antigens, Ly
|
D23.101.100.920 |
|
|
Solid Phase Extraction
|
E05.196.155.800 |
|
|
Fas-Associated Death Domain Protein
|
D12.644.360.024.500.124 |
|
|
Blotting, Western
|
E05.301.300.096 |
|
|
Esophagitis, Peptic
|
C06.405.748.586.524 |
|
|
Animals, Wild
|
B01.050.050.300 |
|
|
Desmoplastic Small Round Cell Tumor
|
D058405 |
[A rare, aggressive soft tissue sarcoma that primarily affects adolescents and young adults. It is most commonly found in the abdomen.
] |
|
Cardiac Resynchronization Therapy
|
D058406 |
[The restoration of the sequential order of contraction and relaxation of the HEART ATRIA and HEART VENTRICLES by atrio-biventricular pacing.
, Electrical stimulation of the heart by artificial pacemaker leads placed at sites in the RIGHT ATRIUM and both HEART VENTRICLES to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles.
] |
|
Nalidixic Acid
|
D03.633.100.612.500 |
|
|
Enzyme-Linked Immunosorbent Assay
|
E05.478.566.380.360 |
|
|
Compomers
|
D25.720.716.822.308.300 |
|
|
Adenosine Deaminase Inhibitors
|
D27.505.519.389.092 |
|
|
Dihydromorphine
|
D03.605.497.607.420 |
|
|
Codon, Initiator
|
G05.360.340.024.340.137.190.225 |
|
|
AraC Transcription Factor
|
D12.776.097.049 |
|
|
Postoperative Care
|
E04.604.500 |
|
|
Thyrotrophs
|
A08.186.211.180.497.352.435.500.500.968 |
|
|
Luteinization
|
D034461 |
[Formation of CORPUS LUTEUM. This process includes capillary invasion of the ruptured OVARIAN FOLLICLE, hypertrophy of the GRANULOSA CELLS and the THECA CELLS, and the production of PROGESTERONE. Luteinization is regulated by LUTEINIZING HORMONE.
] |
